These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16564608)

  • 1. Residues of genotoxic alkyl mesylates in mesylate salt drug substances: real or imaginary problems?
    Snodin DJ
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):79-90. PubMed ID: 16564608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug substances presented as sulfonic acid salts: overview of utility, safety and regulation.
    Elder DP; Snodin DJ
    J Pharm Pharmacol; 2009 Mar; 61(3):269-78. PubMed ID: 19222899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs).
    Elder DP; Lipczynski AM; Teasdale A
    J Pharm Biomed Anal; 2008 Nov; 48(3):497-507. PubMed ID: 18657926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity profiles of common alkyl halides and esters with alkylating activity.
    Sobol Z; Engel ME; Rubitski E; Ku WW; Aubrecht J; Schiestl RH
    Mutat Res; 2007 Oct; 633(2):80-94. PubMed ID: 17644026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Commission for Protection Against Environmental Mutagens and Carcinogens. The subtlety of alkylating agents in reactions with biological macromolecules.
    Vogel EW; Nivard MJ
    Mutat Res; 1994 Feb; 305(1):13-32. PubMed ID: 7508544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of genotoxic impurities in pharmaceutical development.
    Bercu JP; Dobo KL; Gocke E; McGovern TJ
    Int J Toxicol; 2009; 28(6):468-78. PubMed ID: 19966139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs).
    Elder DP; Teasdale A; Lipczynski AM
    J Pharm Biomed Anal; 2008 Jan; 46(1):1-8. PubMed ID: 18053672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerns about the safety of obesity agents from a manufacturing perspective.
    Kanfer I
    Postgrad Med; 2008 Jul; 120(2):42-5. PubMed ID: 18654067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkylating agents stronger than alkyl triflates.
    Kato T; Stoyanov E; Geier J; Grützmacher H; Reed CA
    J Am Chem Soc; 2004 Oct; 126(39):12451-7. PubMed ID: 15453779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity.
    Müller L; Mauthe RJ; Riley CM; Andino MM; Antonis DD; Beels C; DeGeorge J; De Knaep AG; Ellison D; Fagerland JA; Frank R; Fritschel B; Galloway S; Harpur E; Humfrey CD; Jacks AS; Jagota N; Mackinnon J; Mohan G; Ness DK; O'Donovan MR; Smith MD; Vudathala G; Yotti L
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):198-211. PubMed ID: 16412543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development.
    Dobo KL; Greene N; Cyr MO; Caron S; Ku WW
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):282-93. PubMed ID: 16464524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylate.
    Seo JH; Park JB; Choi WK; Park S; Sung YJ; Oh E; Bae SK
    Drug Des Devel Ther; 2015; 9():3961-8. PubMed ID: 26251575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance.
    Bercu JP; Hoffman WP; Lee C; Ness DK
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):270-7. PubMed ID: 18550240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of alkyl mesilates and alkyl besilates in finished drug products by direct injection GC/MS.
    Wollein U; Schramek N
    Eur J Pharm Sci; 2012 Jan; 45(1-2):201-4. PubMed ID: 22115865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.
    Li S; Wong S; Sethia S; Almoazen H; Joshi YM; Serajuddin AT
    Pharm Res; 2005 Apr; 22(4):628-35. PubMed ID: 15846471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-coupling reaction of alkyl halides with grignard reagents catalyzed by Ni, Pd, or Cu complexes with pi-carbon ligand(s).
    Terao J; Kambe N
    Acc Chem Res; 2008 Nov; 41(11):1545-54. PubMed ID: 18973349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A generic approach for the determination of residues of alkylating agents in active pharmaceutical ingredients by in situ derivatization-headspace-gas chromatography-mass spectrometry.
    Alzaga R; Ryan RW; Taylor-Worth K; Lipczynski AM; Szucs R; Sandra P
    J Pharm Biomed Anal; 2007 Nov; 45(3):472-9. PubMed ID: 17719195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances.
    An J; Sun M; Bai L; Chen T; Liu DQ; Kord A
    J Pharm Biomed Anal; 2008 Nov; 48(3):1006-10. PubMed ID: 18687555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reichardt's dye and its reactions with the alkylating agents 4-chloro-1-butanol, ethyl methanesulfonate, 1-bromobutane and Fast Red B - a potentially useful reagent for the detection of genotoxic impurities in pharmaceuticals.
    Corrigan DK; Whitcombe MJ; McCrossen S; Piletsky S
    J Pharm Pharmacol; 2009 Apr; 61(4):533-7. PubMed ID: 19298702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.